Which of the following drugs is a SERM useful for treatment of osteoporosis
Refer Katzung 11/e p 759. Raloxifen is a selective estrogen receptor modulator with estrogen agonistic action on bone and antagonistic action on breast and endometrium It is therefore the preferred drug for the treatment and prevention of post menopausal osteoporosis
Raloxifen
Bisphoshonates
Strontium
Estradiol
Endocrinology